If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Thought Leader Services
Download FREE Excerpt
13 Info Graphics
10 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The pharmaceutical industry is constantly changing, and to navigate this new landscape pharmaceutical leaders are focusing on establishing and maintaining deep relationships with thought leaders. Paramount to this effort is having in place internal policies and practices that are focused on effectively managing these critical relationships.
Best Practices, LLC conducted a benchmark study that addressed how the industry is adjusting its approach to organizing, staffing and managing thought leader relationships.
The study provides insights and benchmarks that illustrate how leading pharma and biotech companies organize and structure their Medical Affairs capabilities. In addition, the study examines resource levels for effective Medical Affairs organizations and identifies the critical requirements to create strong Medical Affairs capabilities.
This study will inform medical affairs leaders on current trends and practices on these issues.
Data in this study is presented in segments by company size and global vs. US only.
Thirty-one survey responses from Medical Affairs leaders at 27 biopharmaceutical companies. This report captures insights on Large , Mid-Size and Small companies segments as well as on companies from Global and US-only regions.
Biopharmaceutical; Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Clinical Research; Laboratories
Alkermes; Allergan; Baxalta; Bayer; Celldex Therapeutics; CSL Behring; Genentech; Genzyme; GW Pharmaceuticals; Indivior; Jazz Pharmaceuticals; Mesoblast; Neurocrine Biosciences; Norgine; Novo Nordisk; Perrigo Company; Pfizer; ProStrakan; Sanofi; Santen; Shire; Stallergenes; Sunovion; Teva Pharmaceutical Industries Ltd; Theravance; Tris Pharma; UCB Pharma
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.